Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5572_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
30.08.2026
Размер:
49 Мб
Скачать
Herbal Medicine fortheManagement ofAnxiety, Depression, andInsomnia
https://t.me/medicina_free
(continued)
Table 2
Plant name/Family Constituents Foeniculum vulgare miller
Apiaceae Humulus lupulus
L.Cannabaceae
Hyoscyamus niger L.Solanaceae
Hypericum perforatum L Hypericin, hyperforin, quercetin, kaempferol,
Ilex aquifolium L.Aquifoliaceae
Lactuca sativa L.Asteraceae Quercetin Antioxidant, antimicrobial, anxiolytic,
Laurus nobilis L.Lauraceae Pinene, terpineol, quercetin, kaempferol,
Lavandula angustifolia miller Lamiaceae
Lavandula ofcinalis Chaix Lamiaceae
Lavandula stoechas L.Lamiaceae
Leucanthemum alpinum lam. Asteraceae
Lolium multiorum lam. Poaceae
Lolium perenne L.Poaceae Quercetin Antioxidant, Lotus corniculatus
L.Fabaceae
Malva cretica Cav. Malvaceae Isoquercetin, quercetin, rutin, kaempferol,
Malva neglecta Wallr. Malvaceae
Malva sylvestris L.Malvaceae
Matricaria camomilla L. (=Chamomilla recutita (L.) Rauschert) Asteraceae
Matricaria discoidea DC.Asteraceae
Melilotus ofcinalis pall. Fabaceae
Rutin, quercetin, apigenin, and caffeic acid Antioxidant, antimicrobial, hypnotic,
Humulone, lupulon, naringenin, quercetin, kaempferol, and taxifolin
Chlorogenic acid, rutin, quercetin, and scopolamine
biapigenin, and rutin
Quercetin, rutin, kaempferol, and chlirogenin acid
luteolin, and apigenin
Isoquercetin, quercetin, rutin, kaempferol, and apigenin
Borneol, cineole, and linalool, Antioxidant, antimicrobial, anxiolytic,
Lupeol, amyrin, vanillin, rutin, luteolin, and apigenin
Flavonoid Antioxidant
Chorogenic acid, Isoquercetin, quercetin, rutin, kaempferol, apigenin,luteolin, and ferulic acid
Quercetin, rutin, kaempferol, isorhamnetin, luteolin, and biochanin
apigenin, and luteolin Isoquercetin, quercetin, rutin, kaempferol,
apigenin, luteolin, chrysin, coumarin, gallic acid, and vanillin
Isoquercetin, quercetin, rutin, kaempferol, apigenin, and luteolin
Quercetin, rutin, kaempferol, apigenin, and luteolin
Chorogenic acid, Isoquercetin, quercetin, rutin, kaempferol, apigenin,luteolin, isorhamnetin, and cosmosin
Coumarin, Isoquercetin, quercetin, rutin, kaempferol, and apigenin
Active biomolecule(s) Pharmacological effects
anxiolytic, antidepressant, and antiamnesic Antioxidant, anxiolytic, insomnia,
antibacterial, antifungal, anti­inammatory, and sedative-hypnotic antidepressant
Antioxidant, antimicrobial, sedative­hypnotic, and calming agent (anxiolytic) antidepressant
Antioxidant, antimicrobial, anxiolytic, anti-inammatory, sedative-hypnotic antidepressant, and anti cancer
Antioxidant, antimicrobial, anxiolytic, and sedative-hypnotic
sedative-hypnotic antidepressant, and analgesic
Antioxidant, anxiolytic, anti-inammatory, analgesic, sedative-hypnotic, and antimicrobial
Antioxidant, anxiolytic, anti-inammatory, and sedative-hypnotic
anti-inammatory, and sedative-hypnotic Antioxidant, anxiolytic, anti-inammatory,
antifungal, and sedative-hypnotic
Anti oxidant, anti-inammatory, and antimicrobial
Antibacterial, antioxidant, anxiolytic, antidepressant, anti-inammatory, sedative-hypnotic, anticancer,
Antioxidant, and anxiolytic
Antioxidant, anxiolytic, antimicrobial, anticholinesterase, anti-inammatory, and sedative-hypnotic
Antioxidant, anxiolytic, anti-inammatory, antifungal, and sedative-hypnotic
Antioxidant, anxiolytic, anti-inammatory, antispasmodic, antidepressant, sedative­hypnotic, hypolipidemic, anticonvulsant, antiparasitic, an analgesic
Antioxidant, anxiolytic, anti-inammatory, antispasmodic, antidepressant, sedative­hypnotic, hypolipidemic, anticonvulsant, antiparasitic, and analgesic
Antioxidant, antimicrobial, antibiolm, anxiolytic, anti-inammatory, anticancer, sedative-hypnotic, and analgesia
(continued)
259
260
https://t.me/medicina_free
(continued)
Table 2
Plant name/Family Constituents Melissa ofcinalis
L.Lamiaceae
Melittis melissophyllum L.Lamiaceae
Mentha aquatica L.Lamiaceae
Mentha piperita L.Lamiaceae Epicatechin, syringic acid, Isoquercetin,
Mentha spicata L. (=M.Spicata L. subsp. glabrata (Lej. and Courtois) Lebeau) Lamiaceae
Mentha suaveolens Ehrh. Subsp. suaveolens Lamiaceae
Mentha viridis L.Lamiaceae Quercetin, rutin, and kaempferol Antioxidant, anxiolytic, antimicrobial,
Myrtus communis L.Myrtaceae
Nepeta cataria L.Lamiaceae Chlorogenic acid, quinic acid, Isoquercetin,
Ocimum basilicum L.Lamiaceae
Olea europaea L.Oleaceae [17]
Opuntia cus-indica (L.) mill. Cactaceae
Origanum majorana L.Lamiaceae
Origanum vulgare L. subsp. viridulum (Martrin-Donos) Nyman Lamiaceae
Paeonia mascula (L.) mill. Paeoniaceae
Papaver rhoeas L.Papaveraceae [19]
Papaver setigerum DC.Papaveraceae [20]
Papaver somniferum L.Papaveraceae
Pimpinella anisum L.Apiaceae [21]
Isoquercetin, quercetin, rutin, kaempferol, apigenin, and rhamnocitrin
Myricetin,, quercetin, rutin, kaempferol, apigenin, and luteolin
Isoquercetin, quercetin, rutin, kaempferol, apigenin, luteolin, and naringenin
quercetin, rutin, kaempferol, apigenin, and luteolin
Quercetin, rutin, kaempferol, apigenin, and luteolin
Isoquercetin, rutin, and apigenin Antioxidant, anxiolytic, antibacterial,
Linalool, myrecitin, Isoquercetin, quercetin, rutin, kaempferol, and apigenin
quercetin, myricetin, nd apigenin,
Isoquercetin, quercetin, rutin, kaempferol, apigenin, catechin, naringin, and genistein
Luteolin, diosmetin quercetin, rutin, kaempferol, apigenin, and oleuropein
Isoquercetin, quercetin, rutin, kaempferol, apigenin, and isorhamnetin[18]
Quercetin, rutin, apigenin, naringenin, luteolin, and scutellarein
Quercetin, rutin, apigenin, naringenin, luteolin, and scutellarein
Isoquercetin, quercetin, rutin, kaempferol, and apigenin
Isoquercetin, quercetin, rutin, kaempferol, and apigenin
Quercetin, ruti,, and apigenin Antioxidant, anxiolytic, anti-inammatory,
Isoquercetin, quercetin, rutin, kaempferol, apigenin, and luteolin
Quercetin, rutin, kaempferol, and apigenin Antioxidant, anxiolytic, antimicrobial,
Active biomolecule(s) Pharmacological effects
Antioxidant, anxiolytic, antibacterial, antiviral, anti-Alzheimer, anti­inammatory, antidepressant, sedative­hypnotic, cardioprotective, antidiabetic, and analgesic
Antioxidant, anxiolytic, anti-inammatory, antifungal, and sedative-hypnotic
Hepatoprotection, antioxidant, anxiolytic, anti-inammatory, analgesic, sedative, appetite stimulant, and anticonvulsant
Antispasmodic, antioxidant, anxiolytic, anti-inammatory, analgesic, sedative, and antidepressant
Antioxidant, antimicrobial, anxiolytic, anti-inammatory, sedative-hypnotic, antidepressant, and cytotoxic
anti-inammatory, analgesic, sedative-hypnotic
anticancer, and anti-inammatory Antioxidant, anxiolytic, antimicrobial,
anti-inammatory, anticancer, antidepressant, and sedative-hypnotic,
Antioxidant, anxiolytic, antimicrobial, antidepressant, anti-inammatory, and sedative-hypnotic
Antioxidant, anxiolytic, anti-inammatory, and sedative-hypnotic
Antioxidant, anxiolytic, neuroprotective, anti-inammatory, analgesic, antifungal, sedative-hypnotic, and anti-tumor
Antioxidant, anxiolytic, antibacterial, anti-inammatory, analgesic, sedative­hypnotic, antidepressant. Anticancer, neuroprotective, and anti-viral
Antioxidant, anxiolytic, anti-inammatory, and sedative-hypnotic
Antioxidant, anxiolytic, antimicrobial, antidepressant, anti-inammatory, antifungal, and sedative-hypnotic
Antioxidant, antimicrobial, anxiolytic, analgesic, anti-inammatory, and anticholinesterase
Antioxidant, anxiolytic, anti-inammatory, and sedative
antifungal, and sedative Antioxidant, anxiolytic, anti-inammatory,
antifungal, and sedative-hypnotic
analgesic, anti-inammatory, antispasmodic, antidepressant, sedative­hypnotic, antiviral, and anticonvulsant
S. O. Otimenyin
Herbal Medicine fortheManagement ofAnxiety, Depression, andInsomnia
https://t.me/medicina_free
(continued)
Table 2
Plant name/Family Constituents Polypodium vulgare
L.Polypodiaceae
Primula veris L.Primulaceae Quercetin, rutin, kaempferol, apigenin, Antioxidant, anxiolytic, and
Primula vulgaris Huds. Primulaceae
Prunus persica (L.) Batsch Rosaceae
Robinia pseudacacia L.Fabaceae
Rosmarinus ofcinalis L.Lamiaceae
Ruta chalepensis L.Rutaceae Quercetin, rutin, kaempferol, and apigenin Antioxidant, anxiolytic, antimicrobial,
Salix alba L.Salicaceae Quercetin, rutin, and salicin Antioxidant, anxiolytic, anti-inammatory,
Salvia ofcinalis L.Lamiaceae
Santolina insularis (Gennari ex Fiori) Arrigoni Asteraceae
Senecio delphinifolius Vahl. Asteraceae
Solanum nigrum L.Solanaceae [22]
Sonchus oleraceus L.Asteraceae
Stachys recta L.Lamiaceae Caffeoylquinic acid, rutin, and avonoids Antioxidant, anxiolytic, and
Tanacetum balsamita L. (=Balsamita major Desf.) Asteraceae
Thalictrum aquilegiifolium L.Ranunculaceae
Thymbra capitata (L.) Cav. Lamiaceae [23]
Valeriana ofcinalis L.Valerianaceae [24]
Catechin, kaempferol, and apigenin Antioxidant, anxiolytic, antimicrobial,
Quercetin, rutin, and kaempferol Antioxidant, anxiolytic, anti-inammatory,
Quercetin, rutin, kaempferol, apigenin, and cinnamic acid
Myricetin, chorogenic acid, isoquercetin, quercetin, rutin, kaempferol, apigenin, naringenin, chrysoeriol, and isoliquiritigenin
Ferulic acid, rosmarinic acid, chorogenic acid, Isoquercetin, quercetin, rutin, kaempferol, apigenin, chlorogenic acid, and rosmaric acid,
Quercetin, rutin, hesperidin, luteolin, apigenin, chrysin, sagerinic acid, pinocembrine, catechin, and cirsimaritin
, Luteolin, rhamnocitrin, andnepetin Antioxidant, anxiolytic, and
Quercetin Antioxidant, anxiolytic, anti-inammatory,
Quercetin, rutin, apigenin, apigenin, and luteolin
Isoquercetin, nepetin, kaempferol, axillarin, quercetin, rutin, apigenin, naringenin, luteolin, scutellarein, isoramnetin, hyperoside, and syringic acid [18]
Thalifoline Antioxidant, anxiolytic, and anti-fungal
Rosmarinic acid, quercetin, rutin, kaempferol, and apigenin
Valerenic acid Insomnia
Active biomolecule(s) Pharmacological effects
analgesic, anti-inammatory, antidepressant, sedative-hypnotic, antiviral, and anticonvulsant
anti-inammatory
and sedative-hypnotic Antioxidant, anxiolytic, antimicrobial,
anti-inammatory, antispasmodic, antidepressant, sedative-hypnotic, anticholinesterase, anti-obesity, and hepatoprotective
Antioxidant, anxiolytic, antimicrobial, anti-inammatory, antifungal, antidepressant, inhibits interleukin-1B, and antiviral
Antioxidant, anxiolytic, antimicrobial, analgesia, anti-inammatory, neuroprotective, sedative-hypnotic, antitumor, and anticonvulsant
antipyretic anti-inammatory, antidepressant, sedative-hypnotic, and anticonvulsant
and analgesia Antioxidant, anxiolytic, and antimicrobial
anti-inammatory Antioxidant, anxiolytic, anti-inammatory,
cytotoxic
and antidiabetic Antioxidant, antimicrobial, anxiolytic,
gastroprotective, anti-inammatory, and anti-cancer
anti-inammatory Antioxidant, anxiolytic, anti-inammatory,
and ant-spasmodic
Antioxidant, anxiolytic, and anti-inammatory
Restlessness
Insomnia Restlessness
261
262
https://t.me/medicina_free
Table 3 Mechanism of selected avonoids found in anxiolytic and sedative/hypnotic plants
Name Similar brain chemical Uses/effects Mechanism(s) 7, 8-dihydroxyavone [25] Anti-depressant and
Parkinson’s disease
Amentoavon [25] Cnestis ferruginea Vahl
ex DC
Apigenin [27] Antioxidant, anti-
Baicalein (5, 6, 7-trihydroxyavone)
Chrysin Found in honey Antineoplastic, antioxidant,
Luteolin [30] (3, 4 5, 7, tetrahydroxyavone)
Orientin Highly abundant in
Nobiletin (5,6,7,8,3,4-hexamethoxyavone)
Icariin Anti-depressant [31] Icarin inhibits inducible nitric oxide
Vitexin (is an apigenin avone glucoside)
Fisetin (7, 3, 4-avon-3-ol)
Scutellaria baicalensis Georgi
Cirsium japonicum Var. Maackii
herbs, fruits, and millet
Passiora incarnates L. Antitumor, anti-
Fruits (especially strawberries) and vegetables are rich in setin
Neuroprotective action, antioxidant, and anti­inammatory anxiolytic and antidepressant
inammatory, anti depressant, and antitumor activities [28, 29]
Antioxidant antidepressant Increase ERK phosphorylation and elevate
anti-inammatory, antidepressant, and hypolipidemic
Anticancer, antioxidant, anxiolytic, memory-boosting properties, and antidepressant effects
Antioxidant activity and antidepressant
Neuroprotection Anti-depressant
inammatory, analgesic, and antioxidant Anxiolytic and anti­depressant activities
Anti-inammatory, antioxidant, and neuroprotective antidepressant
It acts on activated TrkB (tropomyosin receptor kinase B) receptors and nitric oxide signaling pathway It mimics brain-derived neurotrophic factor (BDNF) and also elevates BDNF expression and levels in the hippocampus [26]
Acts via interactions with serotonin (5-HT2), ionotropic GABA (gamma­aminobutyric acid), and adrenergic receptors (α1- and α2-), [26]
Apigenin inhibits NLRP3 inammasome expression, upregulates PPAR (peroxisome proliferator-activated receptor) expression, and inhibits IL-1 production. Up-regulates the level of BDNF in the hippocampal region of the brain and inhibits mono-amino oxidase enzyme
hippocampal BDNF expression Increase levels of BDNF and dopamine in the hippocampus Inhibit cyclooxygenase
Chrysin up-regulates BDNF expression and elevates BDNF levels in the hippocampus and prefrontal cortex It also modulates 5-hydroxy-tryptamine metabolism, caspase activities, pro­inammatory cytokines synthesis, and kyanize
Actions are mediated via potentiation of GABA-A Decrease stress-related protein of the endoplasmic reticulum, Inhibit the MAO enzyme resulting in an increase in CNS neurotransmitter levels
Increases amine neurotransmitters in the brain by inhibiting MAO and increases synaptic proteins and BDNF expression in the prefrontal cortex and hippocampus
Noboletin interaction with dopaminergic (D1 and D2), noradrenergic (α1), receptors, and serotonergic (5-HT1A and 5-HT2) receptors
synthase enzyme activity. It also elevates hippocampal BDNF levels [32, 33]
Vitexin inhibits urease, platelet aggregation, α-glucosidase, and adipogenesis Mediated via interaction with serotonergic(5-HT1A), dopaminergic (D1, D2, and D3), and noradrenergic(α2) receptors. It also increases the synaptic concentration of this neurotransmitter
Its action is mediated via activation of the TrkB signaling pathway and leads to an increase in phosphorylation of TrkB level without disturbing total TrkB
S. O. Otimenyin
Herbal Medicine fortheManagement ofAnxiety, Depression, andInsomnia
https://t.me/medicina_free
(continued)
Table 3
Name Similar brain chemical Uses/effects Mechanism(s) Isoquercitrin St. John’s wort Anti-depressant
Kaempferitrin Justicia spicigera
Kaempferol Fruits and vegetables Anti-depressant [35]
Myricetin In fruits, red wine,
Myricitrin [36] Antidepressant, antioxidant,
Quercetin [38]
Rutin Vegetables, citrus
Flavanone Anti-inammatory and
Hesperidine hesperidin Antidepressant
Naringin (4-hydroxyavanones)
Naringenin Citrus fruits peel Anti-inammatory,
Silibinin Cardioprotective
Flavan-3-ols ()-epicatechin and (+)-catechin
Astilbin Hypericum perforatum Anti-inammatory
Dihydromyricetin Cercidiphyllum
Schltdl
berries, vegetables, nuts, and tea
Broccoli, wine, apple, onion, and plants (e.g., Green tea), [39]
fruits, and plants (such as gs, green, and black tea
Cocoa Uncaria rhynchophylla (Miq
japonicum Salix sachalinensis
Antioxidant [34]
Anti-depressant Regulates the HPA axis and modulates the
Anti-apoptotic Anti-inammatory, anti­depressant, antioxidant, and neuroprotective
anti-brotic, and anti­inammatory [37]
Anti-depressant [40] Antiinfamatory
Anti-inammatory, neuroprotective, anti-tumor, and antioxidant
antioxidant
Antioxidant
Antioxidant, antidepressant, Anticarcinogenic, and blood lipid-lowering
antioxidant, neuroprotective, cognition enhancer, anti-bacterial, and wound-healing
Anti-inammatory Anticancer Anti-depressant [41]
Anxiety and depression Inhibiting MAO-B enzyme activity
antioxidant, and antidepressant [42]
Anti-depressant Increase in BDNF expression and inhibit
Isoquercitin elicits these actions via the modulation of hypothalamus/pituitary axis (HPA) functions. It prevents hypersecretion of adrenocorticotropic hormone and cortisol
serotonergic system (mainly, presynaptic 5-HT1A receptors)
Elevates plasma β epinephrine, dopamine, and serotonin (reduces serotonin metabolism) concentration
Increases the activity of enzyhippocampus glutathione peroxidase and BDNF level
Inhibition of MAO enzyme
Elevates CNS monoamine level and increases hippocampal BDNF and expression
Increase in hippocampal BDNF concentrations, activate dopaminergic systems, and enhance 5-HT1A receptors. It also inhibits monoamine oxidases and suppresses neuro-endocrine signaling
Inhibits cytochrome P450 enzymes (CYP1A2)
MAO inhibitor Suppress neuro-endocrine signaling
Alters endocrine, immunological, and monoamines (5-HT, DA, and NE). Alters MDA formation, IL-6, TNF-α, and BDNF levels
Up regulates neurotransmitter release and BDNF signaling pathway [43]
neuro-inammation [44]
263
-endorphin, nor-
264
https://t.me/medicina_free
S. O. Otimenyin
5 Anxiety
Anxiety is one of the most common mental illnesses plagu­ing one-eighth of the total population and has become of great economic burden in most countries. It is a psychiatric problem that is not easily recognized and attended to. Anxiety is a persistent feeling of apprehension, dread, and impending disaster, or uneasiness and/or tension. It is a precise class of psychopathology that presents with future-oriented appre­hension and increased threat value associated with mental, physical, and social stimuli. Anxious people may commit crimes to cover up the source or cause of anxiety.
Over the years, anxiety has received great attention. This has led to the discovery of a number of drugs thought to be of help in managing anxiety. As a central nervous system (CNS) disorder, it has become a very important area of research in psychopharmacology. Stress often precedes anxi­ety, hence the word “‘stress-induced anxiety.” Anxiety is a common psychiatric problem that has been aggravated by the style of this modern world and lifestyles. Pressure from work, pairs groups, families, and self-ambition are some of the numerous predisposal to anxiety. As humans, it is in our traits to be a little stressed and anxious, this is healthy for the progress and development of the human race and for achiev­ing great ts. Stress and anxiety could motivate an individual and spur such to be more productive. Too much of everything appears to be bad in all areas, so also in stress and anxiety. It could cripple an individual if such an individual is stressed beyond boundaries and over anxious. It could result in poor health as well as specic psychological or physical illnesses like depression and insomnia. The inability to control persis­tent stress can lead to anxiety and unhealthy behaviors. Anxiety is a common emotional phenomenon in humans, and it is an unpleasant emotional state that is associated with concern or fear about some dened or undened future threat, uneasiness, and discomfort.
Anxiety, as presented in normal individuals, is character­ized by
2. Symptoms of anxiety include (a) physiological, (b) cog­nitive, and (c) behavioral symptoms.
(a) Cognitive distortions, lack of attention, interpreta-
tion, and memory for information processing [10].
(b) Physiological aspects of anxiety include autonomic
or somatic sensations. It also includes avoidance related to nightmares, sleep, insomnia, and fear of sleeping alone. Increased heart rate, heart palpita­tions, shortness of breath, chest pain, nausea, and dif­culty in swallowing.
(c) Behavioral aspects of anxiety disorders include:
avoidance of self-acclaimed fearful events, avoid­ance of specic stimuli (individual, things) that are presumed to make the subject fearful (e.g., bridges), or avoidance of situations (e.g., public speaking) that make the sufferer uncomfortable. These results in the inability to carry out or maintain daily routines in academic, family, and/or social functions.
Anxiety disorders are disturbing psychiatric disorders
affecting all the population. About 30.5% of women and
19.5% of men are affected and nearly 25% of the adult popu-
lation at some point in their life is affected. Young adults are more plagued with anxiety, attention must be given to this population if the nation is to have a future. Anxiety can aggravate many physical and mental ailments and also impede recovery from any other problems.
Identifying the cause of the anxiety (anxiogenic stimulus) may be the way to go in the management of anxiety. A sub­ject may experience anxiety at a particular moment when the causative factor is present. The levels of anxiety in this case depend on the level of the anxiogenic stimulus. This can be referred to as “State anxiety”, and it varies from time to time depending on the presence of the stimulus. Some subjects experience an enduring anxiety (“Trait anxiety”) that cannot be tied to a particular cause. This type of anxiety does not vary from moment to moment; it endures in the subject and may become a feature of the subject.
1. heart palpitations
2. nausea and fatigue
3. shortness of breath and respiratory insufciency
4. fear of the unknown
5. over reaction to minor issues
6. and inability to make progress
5.1 Symptoms ofAnxiety
1. Trembling, sweating, feelings of choking, abdominal dis­tress, nausea, dizziness, pins and needles, feelings of impending doom, or losing control over minor issues.
5.2 Management ofAnxiety
There are orthodox medicines known to improve the life­style of subjects with anxiety, but these drugs have side effects that interfere negatively with the lifestyle of the subject. Most subjects resort to psychotherapy and the use of herbal medicinal agents. Research has isolated herbal preparations that are helpful in the management of anxiety. Herbal medicines seem to work well for those subjects with mild to moderate symptoms of anxiety and sleep dis­orders. The use of natural or herbal remedies for the man­agement of disease conditions by man has increasingly
Herbal Medicine fortheManagement ofAnxiety, Depression, andInsomnia
https://t.me/medicina_free
265
gained attention in recent times, partly because of the high cost of drugs and because of the side effects and non­acceptability. Some believe that evil spirits are responsible for CNS disease, and they use herbs and incantations to ward away the spirits and regain normalcy. This method works, not because spirits are driven away, but as a form of psychotherapy and distractor from the cause of anxiety or any related CNS disorders. Different types and forms of herbal medications are used for self- treatment of various stress-related afictions. Research studies have shown that some of these plants have one or more CNS effects. Research studies into many that have not been researched have been advocated.
5.3 Types ofAnxiety Disorders
Anxiety disorders encompass the following clinical conditions
1. Panic disorder
2. Social anxiety disorder and phobias
3. Generalized anxiety disorder
4. Post-traumatic stress disorder
5. Obsessive–compulsive disorder.
5.3.1 Generalized Anxiety Disorders
This disorder involves a broad presentation of anxiety. Generalized anxiety disorder presents with long-lasting anxiety that may span up to or over 6months. Such anxiety may have more than one causative situation and may not be focused on one causative object or situation. Subjects with this type of anxiety experience persistent fear (non-specic– cannot be traced to a real fear stimulant) and worry (when there is no cause to worry) and become overly disturbed with everyday stuff like health, money, work, family, and experi­ence these symptoms even when there are no clear signs of trouble in this aspect of their life.
times difculty in breathing, lasting for a few minutes or lon­ger. The patient believes that he is seriously sick or about to die. This feeling can leave the person shaken or depressed immediately after the experience and for a period of time. Panic disorder results in marked impairment in function if it continues for a sustained period of time.
5.3.4 Social Anxiety Disorder
Social anxiety disorder is a marked and persistent fear of performance or social situations. The person feels he is not measuring up with social requirements and obligations.
5.3.5 Phobias
A phobia is an exaggerated or unrealistic fear of a specic stimulus: darkness, heights, enclosed places, cooking re, or other situations. Phobic individuals sometimes experience full panic attacks after exposure to unrealistic stimuli. Phobia seems the most common form of anxiety disorder. Panic dis­orders are not common and are fairly rare occurrencesin the general population.
5.4 Physiology ofAnxiety
The brain is a complex organ and is the center of the human nervous system. It controls the “mind” and the physical activities. Its importance explains why it is well secured and protected from the outside world and most chemical agents that may interfere with its functioning. The Locus ceruleus and the amygdala in the brain trigger a response to danger and the acquisition and expression of fear conditioning, respectively. Over activity/hyperactivity in the locus ceru­leus transmits signals to the amygdala, which is sensed as danger. The resultant instinct is the instruction to run from danger and activation of the heart to beat faster, the lungs to take in more air (breathing to become rapid), and in turn, activates all the biological components of ght/ight response.
5.3.2 Obsessive–Compulsive Disorder
This type of anxiety disorder presents with obsessions; recurrent thoughts of danger or threat that do not exist or may not be about real-life threat or problem, which the patient fails to suppress or ignore. Compulsions present as repetitive behaviors that the patient feels pushed to execute in response to an obsession. The compulsive behaviors are thought to be an attempt to reduce the distress from the obsessions. The behaviors may not be benecial to the per­son or the community.
5.3.3 Panic Disorder
Subjects with this disorder present with apprehension and brief attacks of intense terror, which is often characterized by shaking, confusion, trembling, dizziness, nausea, and some-
5.4.1 Symptoms ofAnxiety
• Increase in breathing rate and increase in heartbeat
• Trembling/twitching
• Muscle contraction
• Headaches
• Sweating
• Difculty in swallowing/dry mouth
• Abdominal pain Other symptoms include:
• Dizziness/blurred vision
• Sexual problems
• Diarrhoea or urinary urgency
• Irritability/loss of temper
• Fearful dreams, nightmares, or/and sleeping difculties
• Decreased concentration
266
https://t.me/medicina_free
S. O. Otimenyin
The symptoms of anxiety are normal to every individual, and it is intended for the safety of the person. It is a series of events that alert the person to danger and proffer a solution to be safe. In most cases, it signals the person to run from the point of danger. A problem arises if these responses proceed beyond normal.
5.5 Mechanism ofAnxiety
The brain performs its functions by varying the concentra­tions of neurotransmitters at various synapses, varying the population of receptors expressed on the recipient cells, and altering the state of the neurons in it. Anxiety is a recognized state of the brain, which is known to be one of the most important emotional processes with rm neurobiological roots. The mechanism of anxiety and its neurochemistry is not well understood. This has made it a major area of research, and the outcome of this research has led to new approaches to the management of anxiety. Anxiety is thought to occur as a result of an imbalance in the neurochemistry of the brain. Some neurochemicals are on the high side while others are very low. A number of neurotransmitters are thought to be involved in anxiety. The levels of these neu­rotransmitters determine the type of anxiety, and the ease to resolve and manage. Neurochemicals that may be involved are acetylcholine, adrenaline, dopamine, endorphins, sero­tonin, gamma amino butyric acid, glutamate, etc.
The brain is complex and difcult to isolate parts for in­depth research that could give a clue to understanding its action. Most research has been centered on the drugs that have an effect on the brain: either worsening a disease condi­tion or alleviating the disease condition. In the case of anxi­ety, most information has come from studying the action of anxiety-reducing or anxiolytic drugs on the brain: their effects on the levels of the neurochemicals at known regions of the brain. The results obtained when compared with a non-anxious brain reveal that anxiety is caused by the dys­function of one or more neurotransmitters and their recep­tors. The gamma amino butyric acid (GABA) mechanisms, the serotonergic system, noradrenergic mechanisms, and neuropeptides have been implicated in anxiety. Adenosine and cholecystokinin have also been implicated in anxiety.
GABA is an inhibitory neurotransmitter in the brain, and it regulates neuronal excitability, a mechanism by which it eases stress and calms the brain. The GABA receptors (espe­cially GABAA receptors) regulate the neuronal excitability that is responsible for rapid mood changes (e.g., panic, anxi­ety, and stress response) via fast inhibitory synaptic trans­missions. Drugs that sedate the brain (e.g., benzodiazepines, barbiturates, neurosteroids, and ethanol) are thought to act via GABAA receptors. These drugs elevate GABA levels or enhance GABA-mediated transmission and are known to be
targets of sedating drugs. Action such as alteration of the inux of chloride ions within this receptor complex is associ­ated with the development of anxiety. All commonly used anti-anxiety agents (barbiturates, benzodiazepines, and etha­nol) selectively enhance only GABA-mediated transmission, exerting anti-anxiety, relaxing, and anti-convulsant effects.
Serotonin/serotonin receptors have long been implicated in anxiety in various animal models. Reduced levels of sero­tonin and its action on the serotonin 1A (5HT1A) receptor can produce anxiolytic effects. Serotonin 1A receptor sub­type (5-HT1A) is an autoreceptor located presynaptically on serotonin neurons. When stimulated, this receptor inhibits the synthesis and release of serotonin, thereby reducing its post-synaptic activity. This action mimics the action of a serotonin antagonist (which causes sedation) in the brain. Buspirone, a 5 HT 1A agonist, exhibits anxiolytic effects in animals and is useful in the treatment of generalized anxiety disorder but not in panic disorder. The 5-HT2A, 5-HT2C, and 5-HT3 receptors are also thought to be involved in the mechanism of anxiety.
The neurotransmitter released from adrenergic nerves in the brain, noradrenaline, is helpful in situations of emergen­cies or ght/ight response. Noradrenaline is elevated in these emergencies, but when its levels are elevated when there is no danger or emergencies, anxiety, fear, and irritabil­ity states are produced.
6 Neurotransmitters inAnxiety
6.1 Dierent Neurotransmitters Involved
inAnxiety
6.1.1 Gamma-Amino Butyric Acid
1. The main inhibitory neurotransmitter in the brain is the
Gamma-amino butyric acid (GABA). Anxiety regulation is centered on GABA.GABA is the target of most drug therapies.
2. GABA controls excitability states in areas of the brain.
The brain state at a particular point in time is determined by the equilibrium between inhibitory GABAergic activ­ity and excitatory inputs (mostly glutamatergic).
3. Sedation often implies that the balance is swinging
toward GABA. The subject may also experience ataxia and/or amnesia.
4. Arousal, anxiety, restlessness, insomnia, and exaggerated
reactivity result from the mildest attenuation of the GABAergic system.
6.1.2 Glutamate
1. L-glutamate in the mammalian brain and spinal cord has
been known to be the main excitatory transmitter in the brain since the 1950s.
Herbal Medicine fortheManagement ofAnxiety, Depression, andInsomnia
https://t.me/medicina_free
267
2. Glutamate is the main excitatory neurotransmitter in the central nervous system (CNS).
3. Glutamate is distributed all around the brain (ubiquitous). It plays important roles in brain functions, including acute neurodegeneration (e.g., cerebral ischemia and traumatic brain injury), neurodevelopment (e.g., differen­tiation, migration, and survival), chronic neurodegenera­tion (e.g., Huntington’s disease and Alzheimer’s disease), learning (e.g., long-term potentiation and depression), and, more recently, the stress response and anxiety disorders.
4. Glutamate through its wide range of presynaptic recep­tors controls the synaptic release of neurotransmitters. These controls are effected via the Group II and Group III glutamate metabotropic receptors, cholinergic (nicotinic and muscarinic) receptors, adenosine (A1), kappa opioid, γ-amino butyric acid (GABA B), cholecystokinin, and neuropeptide Y (Y2) receptors.
5. The glutamatergic system plays a major role in the patho­genesis of fear conditioning and anxiety.
6. Glutamatergic neurotransmission in the limbic system plays a pivotal role in the pathogenesis of anxiety disorders.
7. Neuronal damage and/or death are often caused by severe stress exposure, which directly leads to glutamate excitotoxicity.
8. A decrease in the CNS levels of endogenously released glutamate induces anxiolysis. A decrease in brain con­centration of endogenously released glutamate results in the activation of fewer NMDA receptors, but to a less extent the CNS excitation would remain at a stable stage. Such an effect can be achieved by switching on the regulatory machinery of presynaptic glutamate release.
Monosodium glutamate (MSG) [C5H8NO4NaH2O] is one of the avor enhancers. It is sometimes added to food during cooking as an ingredient in various food products. Monosodium glutamate is a sodium salt of naturally occur­ring (non-essential) L-form of glutamic acid. Glutamate is linked to metabolic syndrome and obesity that is not depen­dent on calories ingested and physical activity. It is reported to be neurotoxic, which may be due to over excitation of the neurons.
6.1.3 Serotonin (5HT)
1. The persistence of anxiety disorders and their develop-
ment is controlled by 5-HT and GABA
2. A decrease in central nervous system 5-HT concentration
increases anxiety symptoms, while an increase decreases anxiety symptoms
3. Serotonergic neurons play a major role in sleep, mood,
appetite, cognitive, and energy symptoms in anxiety
4. 5HT modulates the effect on the locus coeruleus and its projections to the amygdale (areas that have a prominent role in anxiety)
5. Stress and fear activate serotonergic pathways in the brain
6. Venlafaxine (an SNRI) inhibits neuronal uptake of 5-HT and resolves the patient’s anxiety
6.2 Management ofAnxiety
The nature or type of the anxiety disorder and the subject’s personality or characteristics determine the drugs that would be used and the method of management of anxiety. Psychotherapy, the use of orthodox drugs, and the use of alternative medications are the options for the management of anxiety.
Drugs: The rst line of drugs for the management of anx­iety (especially generalized social phobia) are the selective serotonin reuptake inhibitors (SSRIs). This class of drugs elevates the serotonin levels in the brain. Examples include uoxetine, sertraline, paroxetine, citalopram, etc. Benzodiazepines are also used in the management of anxi­ety. This class of drugs enhances the effects of GABA in the brain. Examples of benzodiazepines include diazepam, chlordiazepoxide, etc. Monoamine oxidase inhibitors (MAOIs) (phenelzine and moclobemide) prevent the break­down of serotonin and noradrenalin. Beta-blockers like pro­pranolol and atenolol, which reduce the ability to produce adrenaline, are other classes of drugs that are useful in the management of anxiety. The common limitations of anxiety medications or drug therapy include co-morbid psychiatric disorders and an increase in dose leading to unbearable side­effects, such as allergic reactions, nausea, fatigue, drowsi­ness, coordination problems, mental confusion, and addiction liability among others.
Psychotherapy: Activities that can reduce the concentra­tion or activity of stress neurotransmitters or neurochemicals are benecial to subjects with anxiety. Counseling, removal of causative factors of anxiety, provision of needs, etc. may alleviate anxiety states. Cognitive-behavioral therapy and exposure therapy are effective in the management of anxiety disorders. Through psychotherapy, the pattern of thinking (Cognitive therapy) of the subject can be changed; this often diverts the subject’s attention from the causative thoughts. Changes in beliefs that are associated with, and trigger, anxi­ety could also be helpful to the subject. Behavior therapy works when the subject is exposed the reality. Subjects are trained to confront their fears to desensitize them from the anticipated dangers/fears that are triggering anxiety.
Alternative Treatments: Some exercises have a positive impact on subjects with anxiety. Exercises that remould the mind and the thinking and belief of the subjects with anxiety have been found to be benecial. Meditation, a form of mind
268
https://t.me/medicina_free
S. O. Otimenyin
exercise, is benecial to subjects with phobias and panic dis­orders, and it diverts their attention from the causative factor of anxiety (phobia and fear).
Hydrotherapy: Promotes general relaxation of the ner­vous system. Exercise engages the subjects and diverts their focus of thought. Generally, exercise is a natural stress buster and anxiety reliever, and it strengthens the nerves and makes them more resilient. Relaxation techniques (Yoga) could be employed in the management of anxiety. These techniques include progressive muscle relaxation and controlled breath­ing which when practised regularly relieves anxiety. Sensors that measure physiological functions like heart rate, breath­ing, and muscle tension give feedback (biofeedback) that helps recognize the body’s anxiety response. The informa­tion generated helps stimulate subjects to use relaxation techniques. Sleep is an important endeavor of man and ani­mals. It helps to relax the brain and protect it from the out­side world. It refreshes and prepares animals for a new day and events. Most anxious subjects often present with insom­nia caused largely by their fears. Efforts are made through cognitive-behavioral therapy to make subjects sleep. Induction of sleep (Hypnotherapy) involves the application of different therapeutic approaches to help the subject sleep. Sleep often causes a state of deep relaxation (mind and mus­cle relaxation). Medicinal plants with hypnotic activity are benecial in the induction of sleep in anxious subjects. Chinese traditional medicine utilizes acupuncture to help alleviate anxiety. This works under the strong belief that it relaxes the mind and muscles and subsequently may induce sleep.
7 Herbal Anxiolytes
Plants are the major natural resource that are used in alterna­tive medicine. They are used solely or in combination with other natural substances. Plant parts consist of seeds, ow­ers, leaves, stems, and roots. All these parts contain varying concentrations of a particular biomolecule found in that plant. Some plants concentrate some bioactive agent prefer­entially in their leaves, stem, or root. Medicinal plants used for the management of anxiety utilize any of the parts for the treatment of anxiety.
7.1 Isomnia
Insomnia is a state of lack of sleep or inadequate sleep. It can occur if a subject is over stressed. Insomnia is the most com­mon sleep disorder, about one-third of the world population suffers from a long-term derangement of sleep and wakeful­ness [45]. Medicinal plants that have been reported to have hypnotic effects are listed in Table3.
Abnormality in various pathways in the brain has been credited for sleep disorders. Cortisol, GABA receptor and cytokines levels, circadian rhythm (melatonin secretion and adenosine receptors), and excitatory amino acid (glutamate and aspartate) are thought to have malfunctioned/altered to cause insomnia [46].
References
1. German-Ponciano LJ, Rosas-Sánchez GU, Rivadeneyra­Domínguez E, Rodríguez-Landa JF. Advances in the preclini­cal study of some avonoids as potential antidepressant agents. Scientica. 2018;2963565:1–14.
2. American Psychiatric Association. Diagnostic and statistical man­ual for mental disorders, 5a ed (DSM-5). Arlington: American Psychiatric Publishing; 2013.
3. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
4. Taylor DJ, Lichstein KL, Durrence HH.Insomnia as a health risk factor. Behav Sleep Med. 2003;1(4):227–47.
5. Ferrari AJ, Charlson FJ, Norman RE, Patten SB, Freedman G, Murray CJ, Vos T, Whiteford HA.Burden of depressive disorders by country, sex, age, and year: ndings from the global burden of disease study. PLoS Med. 2013;10(11):e1001547.
6. Institute of Health Metrics and Evaluation. Global Health Data Exchange (GHDx). Htts://vizhubhealthdataorg/gbd- results/. Accessed 4 march 2023.
7. Evans-Lacko S, Aguilar-Gaxiola S, Al-Hamzawi A, Alonso J, Benjet C, Bruffaerts R, Chiu WT, Florescu S, de Girolamo G, Gureje O, Haro JM, He Y, Hu C, Karam EG, Kawakami N, Lee S, Lund C, Kovess-Masfety V, Levinson D, Navarro-Mateu F, Pennell BE, Sampson NA, Scott KM, Tachimori H, ten Have M, Viana MC, Williams DR, Wojtyniak BJ, Zarkov Z, Kessler RC, Chatterji S, Thornicroft G.Socio-economic variations in the mental health treatment gap for people with anxiety, mood, and substance use disorders: results from the WHO World Mental Health (WMH) sur­veys. Psychol Med. 2018;48(9):1560–71.
8. Firth J, Marx W, Dash S, Carney R, Teasdale SB, Solmi M, Stubbs B, Schuch FB, Carvalho AF, Jacka F, etal. The effects of dietary improvement on symptoms of depression and anxiety: a meta-analysis of randomized controlled trials. Psychosom Med. 2019;81:265–80.
9. Dwyer AV, Whitten DL, Hawrelak JA.Herbal medicines, other than St. John`s wort, in the treatment of depression. Sci Rev Altern Med. 2011;16(1):281–4.
10. Tegegne MT, Mossie TB, Awoke AA, Assaye AM, Gebrie BT, Eshetu DA.Depression and anxiety disorder among epileptic peo­ple at Amanuel specialized mental hospital, Addis Ababa, Ethiopia. BMC Psychiatry. 2015;15(1):210.
11. Kessler D, Bennewith O, Lewis G, Sharp D. Detection of depression and anxiety in primary care: follow up study. BMJ. 2002;325(7371):1016–7.
12. Unützer J, Klap R, Sturm R, Young AS, Marmon T, Shatkin J, Wells KB.Mental disorders and the use of alternative medicine: results from a national survey. Am J Psychiatry. 2000;157(11):1851–7.
13. Knaudt PR, Connor KM, Weisler RH, Churchill LE, Davidson JR.Alternative therapy use by psychiatric outpatients. J Nerv Ment Dis. 1999;187(11):692–5.
14. Khan RA, Riaz A.Behavioral effects of Citrus Limon in rats. Metab Brain Dis. 2015;30(2):589–96. https://doi.org/10.1007/s11011-
014- 9616- 2. Epub 2014 Sep 17.